Holdings (Monthly)
Guide ↗
Virtus LifeSci Biotech Products ETF
· ETFis Series Trust I| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | DREYFUS GOVERNMENT CASH MANAGE | DGCXX | Jan 2026 | 1,869,136 | $1.9M | 4.17% | STIV |
| 2 | ImmunityBio Inc | IBRX | Jan 2026 | 289,581 | $1.8M | 4.03% | EC |
| 3 | Mirum Pharmaceuticals Inc | MIRM | Jan 2026 | 10,513 | $1.1M | 2.42% | EC |
| 4 | Moderna Inc | MRNA | Jan 2026 | 23,197 | $1.0M | 2.28% | EC |
| 5 | Dynavax Technologies Corp | DVAX | Jan 2026 | 63,278 | $980K | 2.18% | EC |
| 6 | Amicus Therapeutics Inc | FOLD | Jan 2026 | 64,777 | $926K | 2.06% | EC |
| 7 | Novavax Inc | NVAX | Jan 2026 | 104,019 | $920K | 2.05% | EC |
| 8 | Day One Biopharmaceuticals Inc | DAWN | Jan 2026 | 81,747 | $912K | 2.03% | EC |
| 9 | Axsome Therapeutics Inc | AXSM | Jan 2026 | 4,611 | $850K | 1.89% | EC |
| 10 | Ardelyx Inc | ARDX | Jan 2026 | 110,048 | $846K | 1.89% | EC |
| 11 | BioNTech SE | BNTX | Jan 2026 | 7,207 | $820K | 1.83% | EC |
| 12 | GILEAD SCIENCES INC | GILD | Jan 2026 | 5,675 | $806K | 1.80% | EC |
| 13 | Iovance Biotherapeutics Inc | IOVA | Jan 2026 | 310,641 | $792K | 1.77% | EC |
| 14 | HALOZYME THERAPEUTICS INC | HALO | Jan 2026 | 10,984 | $788K | 1.76% | EC |
| 15 | Krystal Biotech Inc | KRYS | Jan 2026 | 2,792 | $780K | 1.74% | EC |
| 16 | Amgen Inc | AMGN | Jan 2026 | 2,150 | $735K | 1.64% | EC |
| 17 | BeOne Medicines Ltd | ONC | Jan 2026 | 2,141 | $729K | 1.62% | EC |
| 18 | BIOMARIN PHARMACEUTICAL INC | BMRN | Jan 2026 | 12,818 | $725K | 1.62% | EC |
| 19 | Kiniksa Pharmaceuticals Intern | KNSA | Jan 2026 | 16,432 | $722K | 1.61% | EC |
| 20 | INCYTE CORP | INCY | Jan 2026 | 7,162 | $717K | 1.60% | EC |
| 21 | THERAVANCE BIOPHARMA INC | TBPH | Jan 2026 | 37,611 | $712K | 1.59% | EC |
| 22 | VERTEX PHARMACEUTICALS INC | VRTX | Jan 2026 | 1,511 | $710K | 1.58% | EC |
| 23 | BIOGEN INC | BIIB | Jan 2026 | 3,923 | $706K | 1.57% | EC |
| 24 | Bridgebio Pharma Inc | BBIO | Jan 2026 | 9,093 | $703K | 1.57% | EC |
| 25 | Ascendis Pharma A/S | ASND | Jan 2026 | 3,100 | $701K | 1.56% | EC |
| 26 | IONIS PHARMACEUTICALS INC | IONS | Jan 2026 | 8,454 | $699K | 1.56% | EC |
| 27 | LIGAND PHARMACEUTICALS | LGND | Jan 2026 | 3,605 | $693K | 1.54% | EC |
| 28 | EXELIXIS INC | EXEL | Jan 2026 | 16,716 | $691K | 1.54% | EC |
| 29 | Geron Corp | GERN | Jan 2026 | 502,509 | $688K | 1.53% | EC |
| 30 | AGIOS PHARMACEUTICALS INC | AGIO | Jan 2026 | 25,060 | $688K | 1.53% | EC |
| 31 | REGENERON PHARMACEUTICALS | REGN | Jan 2026 | 921 | $683K | 1.52% | EC |
| 32 | PTC Therapeutics Inc | PTCT | Jan 2026 | 9,033 | $682K | 1.52% | EC |
| 33 | Syndax Pharmaceuticals Inc | SNDX | Jan 2026 | 33,549 | $681K | 1.52% | EC |
| 34 | Crinetics Pharmaceuticals Inc | CRNX | Jan 2026 | 13,535 | $676K | 1.51% | EC |
| 35 | Arrowhead Pharmaceuticals Inc | ARWR | Jan 2026 | 9,749 | $676K | 1.51% | EC |
| 36 | Roivant Sciences Ltd | ROIV | Jan 2026 | 30,922 | $669K | 1.49% | EC |
| 37 | UNITED THERAPEUTICS CORP | UTHR | Jan 2026 | 1,382 | $649K | 1.45% | EC |
| 38 | SAREPTA THERAPEUTICS INC | SRPT | Jan 2026 | 31,741 | $646K | 1.44% | EC |
| 39 | Phathom Pharmaceuticals Inc | PHAT | Jan 2026 | 46,937 | $642K | 1.43% | EC |
| 40 | TG Therapeutics Inc | TGTX | Jan 2026 | 21,799 | $642K | 1.43% | EC |
| 41 | Zai Lab Ltd | ZLAB | Jan 2026 | 38,457 | $638K | 1.42% | EC |
| 42 | ACADIA Pharmaceuticals Inc | ACAD | Jan 2026 | 25,170 | $633K | 1.41% | EC |
| 43 | KalVista Pharmaceuticals Inc | KALV | Jan 2026 | 40,414 | $631K | 1.41% | EC |
| 44 | Aurinia Pharmaceuticals Inc | AUPH | Jan 2026 | 43,117 | $626K | 1.40% | EC |
| 45 | Rhythm Pharmaceuticals Inc | RYTM | Jan 2026 | 6,017 | $617K | 1.37% | EC |
| 46 | Harmony Biosciences Holdings I | HRMY | Jan 2026 | 16,869 | $616K | 1.37% | EC |
| 47 | Apellis Pharmaceuticals Inc | APLS | Jan 2026 | 27,086 | $612K | 1.36% | EC |
| 48 | Travere Therapeutics Inc | TVTX | Jan 2026 | 19,620 | $610K | 1.36% | EC |
| 49 | NEUROCRINE BIOSCIENCES INC | NBIX | Jan 2026 | 4,472 | $608K | 1.36% | EC |
| 50 | Immunocore Holdings PLC | IMCR | Jan 2026 | 18,569 | $604K | 1.35% | EC |
| 51 | CRISPR Therapeutics AG | CRSP | Jan 2026 | 12,056 | $602K | 1.34% | EC |
| 52 | Esperion Therapeutics Inc | ESPR | Jan 2026 | 177,508 | $602K | 1.34% | EC |
| 53 | ADMA Biologics Inc | ADMA | Jan 2026 | 34,551 | $598K | 1.33% | EC |
| 54 | Arcutis Biotherapeutics Inc | ARQT | Jan 2026 | 23,549 | $597K | 1.33% | EC |
| 55 | LENZ Therapeutics Inc | LENZ | Jan 2026 | 37,674 | $596K | 1.33% | EC |
| 56 | BioCryst Pharmaceuticals Inc | BCRX | Jan 2026 | 90,278 | $594K | 1.32% | EC |
| 57 | Madrigal Pharmaceuticals Inc | MDGL | Jan 2026 | 1,194 | $584K | 1.30% | EC |
| 58 | Alnylam Pharmaceuticals Inc | ALNY | Jan 2026 | 1,717 | $580K | 1.29% | EC |
| 59 | Insmed Inc | INSM | Jan 2026 | 3,468 | $544K | 1.21% | EC |
| 60 | Kura Oncology Inc | KURA | Jan 2026 | 66,870 | $543K | 1.21% | EC |
| 61 | Tarsus Pharmaceuticals Inc | TARS | Jan 2026 | 8,399 | $542K | 1.21% | EC |
| 62 | Legend Biotech Corp | LEGN | Jan 2026 | 30,617 | $536K | 1.19% | EC |
| 63 | ULTRAGENYX PHARMACEUTICAL IN | RARE | Jan 2026 | 18,862 | $454K | 1.01% | EC |
| 64 | Nuvation Bio Inc | NUVB | Jan 2026 | 81,068 | $425K | 0.95% | EC |
| 65 | OmniAb, Inc. | 2200963D | Jan 2026 | 1,295 | $0 | 0.00% | EC |
| 66 | OmniAb, Inc. | 2200964D | Jan 2026 | 1,295 | $0 | 0.00% | EC |